Hematology
Conference Coverage
Minor surgeries appear safe for hemophilia patients on emicizumab
MELBOURNE – Patients with hemophilia A treated with emicizumab can safely undergo minor surgery, often without needing prophylactic coagulation...
News
NOACs benefit early stage chronic kidney disease patients
NOACs reduced risk of several adverse events compared with VKAs in a meta-analysis of chronic kidney disease patients.
News
Gaps in patient-provider survivorship communication persist
Over a recent 5-year period, there was little change in the percentages of patients who reported not having any detailed discussion with providers...
Conference Coverage
No reduction in PE risk with vena cava filters after severe injury
MELBOURNE – “Given the cost and risks associated with a vena cava filter, our data suggest that there is no urgency to insert the filter in...
News
Cancer deaths cost over $94 billion in lost earnings in 2015
“A substantial proportion of the mortality burden is potentially avoidable” with improved prevention and access to care.
Conference Coverage
Insurance-related barriers impede L-glutamine access
FORT LAUDERDALE, FLA. – Just one in five patients prescribed L-glutamine were still taking the drug after 10 months, according to a new real-world...
FDA/CDC
The costs of surviving cancer
Annual out-of-pocket spending is 60% higher for survivors, the CDC reported.
Conference Coverage
Fixed-duration venetoclax-obinutuzumab superior to standard CLL therapy
CHICAGO – The immediately practice changing study offers a time-limited frontline option, one expert reported.